Impact of Introducing Basaglar Insulin to the Treatment Regimen of Youth With Diabetes in Pakistan

计划入组 296 人 · 首次发布于 2024 年 12 月 4 日

Evaluating the Impact of Introducing Basaglar, a Long-acting Analog Insulin, on Clinical and Quality of Life Outcomes in Youth with Diabetes in Bangladesh

计划入组 202 人 · 首次发布于 2024 年 11 月 5 日

The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South Asians

计划入组 119 人 · 首次发布于 2019 年 1 月 29 日

Insulin glargine(Basaglar, Lantus, Rezvoglar, Semglee, Soliqua, Toujeo, Toujeo (previously Optisulin), Abasaglar (previously Abasria), Suliqua, Lusduna)

European Study Shows Biosimilar Competition Drives 21.6% Reduction in Insulin Glargine Prices